Company intelligence / Profile preview
Kairos Pharma Ltd.
Los Angeles, California, USAkairospharma.com ↗
- Ownership
- Public · KAPA
- Development stage
- Phase 2
01
Overview
Kairos Pharma's lead program, ENV105, targets CD105 to reverse drug resistance in multiple cancers. ENV105 has reached Phase 2 trials for castrate-resistant prostate cancer and Phase 1 for EGFR-dependent non-small cell lung cancer. Early preclinical data on additional assets show promise in melanoma and glioblastoma models. Initial safety and interim efficacy results are expected in mid-to-late 2025[4][5][6].
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodiesPeptide inhibitorsImmuno-oncology agents
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
PreCheck Health Servicesmajor medical centers including Cedars Sinai Hospital, University of Utah, City of Hope Cancer Center[4][5]
04
Financials
- Market cap
- $5.1M
- Total revenue
- $0
- Enterprise value
- $2.5M
Beyond the preview
Go deeper on Kairos Pharma Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kairos Pharma Ltd..